NANOBIOTIX To Present First Survival Data From Priority Head And Neck Cancer Program Among Five Presentations At The 2021 Annual Meeting Of The American Society For Radiation Oncology
Poster presentation by Pr. Christophe Le Tourneau featuring first OS and PFS data from phase I expansion study of NBTXR3 as a single agent activated by radiotherapy in tough-to-treat HNSCC population
Oral presentation